Zobrazeno 1 - 10
of 129
pro vyhledávání: '"Miguel Andújar"'
Autor:
Martin Kosar, Michele Giannattasio, Daniele Piccini, Apolinar Maya-Mendoza, Francisco García-Benítez, Jirina Bartkova, Sonia I. Barroso, Hélène Gaillard, Emanuele Martini, Umberto Restuccia, Miguel Angel Ramirez-Otero, Massimiliano Garre, Eleonora Verga, Miguel Andújar-Sánchez, Scott Maynard, Zdenek Hodny, Vincenzo Costanzo, Amit Kumar, Angela Bachi, Andrés Aguilera, Jiri Bartek, Marco Foiani
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-18 (2021)
Tpr nucleoporin is known to be essential for nuclear transport and mitosis processes. Here the authors explore the link between Tpr and genome instability providing insights into the role of Tpr in safeguarding cells from RNA-mediated replication str
Externí odkaz:
https://doaj.org/article/18fbf66c3f8442a6835b1d14c7f9ffa2
Autor:
José Miguel Andújar-Palao, Rodrigo Ormachea-Hermoza, Marcos Fernando Ruiz-Ruiz, Carlos Ricardo Chirinos-Cuadros
Publikováno v:
Revista Venezolana de Gerencia, Vol 26, Iss 94, Pp 784-801 (2021)
A pesar de tener una economía emergente, Perú es uno de los principales productores cupríferos del mundo, sosteniendo gran parte de su desarrollo sobre la base de esta industria. En tal sentido, el objetivo de esta investigación fue analizar el s
Externí odkaz:
https://doaj.org/article/3479c67de6a4468591f65ed3396c405d
Autor:
Miguel Andújar-Sánchez
Publikováno v:
Enfermedades infecciosas y microbiologia clinica (English ed.). 41:259-261
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10c763c94e3d18855832580a37997259
https://doi.org/10.1016/j.eimce.2022.11.022
https://doi.org/10.1016/j.eimce.2022.11.022
Autor:
Dimitris C. Kanellis, Asimina Zisi, Zdenek Skrott, Bennie Lemmens, Jaime A. Espinoza, Martin Kosar, Andrea Björkman, Xuexin Li, Stefanos Arampatzis, Jirina Bartkova, Miguel Andújar-Sánchez, Oscar Fernandez-Capetillo, Martin Mistrik, Mikael S. Lindström, Jiri Bartek
Publikováno v:
Cell Death & Differentiation.
Drug repurposing is a versatile strategy to improve current therapies. Disulfiram has long been used in the treatment of alcohol dependency and multiple clinical trials to evaluate its clinical value in oncology are ongoing. We have recently reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::325a36b9b0cd268632e2140c12998faf
https://doi.org/10.1038/s41418-023-01167-4
https://doi.org/10.1038/s41418-023-01167-4
Autor:
Laura Rodríguez‐Lago, Yeray Peñate, María Teresa Marrero‐Quintana, Miguel Andújar‐Sánchez, Julio Rodríguez‐López
Publikováno v:
Dermatologic Therapy. 35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5669fffd7c2d62ebed9d18397ef043d
https://doi.org/10.1111/dth.15527
https://doi.org/10.1111/dth.15527
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 242:36-42
Objective The goal of this study was to evaluate the demographic characteristics, pathology, treatment, prognostic factors and survival rates in elderly patients with endometrial cancer, and to compare their results with those of younger ones, in ord
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9e634a2fe92e32fea831eb3ac0b5883
https://doi.org/10.1016/j.ejogrb.2019.09.007
https://doi.org/10.1016/j.ejogrb.2019.09.007
Autor:
Andres Rave Ramirez, Miguel Andújar Sánchez, Maria Laseca-Modrego, Alicia Martin Martinez, Octavio Arencibia-Sánchez
Publikováno v:
Cureus
Germ cell tumors represent 20-25% of ovarian tumors, and 95% of them are benign. The most frequent type is the mature benign teratoma (dermoid cysts). The proportion of cases in which malignancy occurs is 0.17-2%. Seventy-five percent to 90% of malig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b8bbf3a070edad1c93e1e8b45c8f290
https://doi.org/10.7759/cureus.12846
https://doi.org/10.7759/cureus.12846
Autor:
Ke Cong, Jiri Bartek, Graeme C. Smith, Sharon B. Cantor, Jinhyuk Bhin, Marieke van de Ven, Miguel Andújar-Sánchez, Mariana Paes Dias, Vivek Tripathi, Stefano Annunziato, Eleni Maria Manolika, Cor Lieftink, Roderick L. Beijersbergen, Jos Jonkers, Ingrid van der Heijden, Jirina Bartkova, Arnab Ray Chaudhuri, Sanjiban Chakrabarty, Sven Rottenberg, Ewa Gogola, Panagiotis Galanos
Publikováno v:
Mol Cell
Molecular Cell, 81(22), 4692-4708.e9. Cell Press
Molecular Cell, 81(22), 4692-4708.e9. Cell Press
SUMMARYInhibitors of poly(ADP-ribose) (PAR) polymerase (PARPi) have entered the clinic for the treatment of homologous recombination (HR)-deficient cancers. Despite the success of this approach, preclinical and clinical research with PARPi has reveal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::438d569285ad1b511368f34691daf54c
https://pubmed.ncbi.nlm.nih.gov/34555355
https://pubmed.ncbi.nlm.nih.gov/34555355
Autor:
Jirina Bartkova, Arnab Ray Chaudhuri, Marieke van de Ven, Panagiotis Galanos, Ke Cong, Sven Rottenberg, Jiri Bartek, Ingrid van der Heijden, Mariana Paes Dias, Jos Jonkers, Cor Lieftink, Sanjiban Chakrabarty, Roderick L. Beijersbergen, Miguel Andújar-Sánchez, Eleni-Maria Manolika, Ewa Gogola, Stefano Annunziato, Sharon B. Cantor, Vivek Tripathi
Publikováno v:
SSRN Electronic Journal.
Inhibitors of poly(ADP-ribose) (PAR) polymerase (PARPi) have entered the clinic for the treatment of homologous recombination (HR)-deficient cancers. Despite the success of this approach, preclinical and clinical research with PARPi has revealed mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97ec8298b9f4f641d772f6b6cadc03c5
https://doi.org/10.2139/ssrn.3707180
https://doi.org/10.2139/ssrn.3707180